Coagulation factor Xa (3.4.21.6)

Industry

CPC
C12N9/6432

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N9/00Enzymes Proenzymes Compositions thereof Processes for preparing, activating, inhibiting, separating or purifying enzymes

Current Industry

C12N9/6432Coagulation factor Xa (3.4.21.6)

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Highly potent ISVD compounds capable of substituting for FVIII(A)
- Patent number 12,098,400
- Issue date Sep 24, 2024
- Novo Nordisk A/S
- Andreas Vegge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Prohemostatic proteins for the treatment of bleeding
- Patent number 12,083,170
- Issue date Sep 10, 2024
- Academisch Ziekenhuis Leiden
- Daniël Verhoef
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Lyophilized formulations for factor XA antidote
- Patent number 12,005,144
- Issue date Jun 11, 2024
- Alexion Pharmaceuticals, Inc.
- Phuong M. Nguyen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Preparation of factor Xa derivatives
- Patent number 11,845,966
- Issue date Dec 19, 2023
- Alexion Pharmaceuticals, Inc.
- Mark Karbarz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antidotes for factor Xa inhibitors and methods of using the same
- Patent number 11,839,646
- Issue date Dec 12, 2023
- Alexion Pharmaceuticals, Inc.
- Genmin Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Peptides that inhibit binding of EPCR to its ligand to treat inflam...
- Patent number 11,820,833
- Issue date Nov 21, 2023
- Tel HaShomer Medical Research Infrastructure and Services Ltd.
- Nicola Maggio
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Prohemostatic proteins for the treatment of bleeding
- Patent number 11,357,836
- Issue date Jun 14, 2022
- Academisch Ziekenhuis Leiden
- Daniël Verhoef
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prohemostatic proteins for the treatment of bleeding
- Patent number 11,304,995
- Issue date Apr 19, 2022
- Academisch Ziekenhuis Leiden
- Daniël Verhoef
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Procoagulant compounds
- Patent number 11,261,437
- Issue date Mar 1, 2022
- Bioverativ Therapeutics Inc.
- Vu Phong Hong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chimeric clotting factors
- Patent number 11,168,316
- Issue date Nov 9, 2021
- Bioverativ Therapeutics, Inc.
- Joe Salas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Mutated factor X polypeptides and uses thereof for the treatment of...
- Patent number 11,085,032
- Issue date Aug 10, 2021
- INSERM (Institut National de la Sante et de la Recherche Medicale)
- Olivier Christophe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Lyophilized formulations for factor Xa antidote
- Patent number 11,028,382
- Issue date Jun 8, 2021
- Alexion Pharmaceuticals, Inc.
- Juan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chimeric clotting factors
- Patent number 10,968,442
- Issue date Apr 6, 2021
- Bioverativ Therapeutics Inc.
- Joe Salas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antidotes for factor Xa inhibitors and methods of using the same
- Patent number 10,954,503
- Issue date Mar 23, 2021
- Alexion Pharmaceuticals, Inc.
- Uma Sinha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Preparation of factor Xa derivatives
- Patent number 10,954,504
- Issue date Mar 23, 2021
- Alexion Pharmaceuticals, Inc.
- Mark Karbarz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Processable single chain molecules and polypeptides made using same
- Patent number 10,927,362
- Issue date Feb 23, 2021
- Bioverativ Therapeutics Inc.
- Joe Salas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Unit dose formulation of antidotes for factor Xa inhibitors and met...
- Patent number 10,765,726
- Issue date Sep 8, 2020
- Portola Pharmaceuticals, Inc.
- Uma Sinha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Protein purification by anion exchange chromatography
- Patent number 10,723,761
- Issue date Jul 28, 2020
- Baxalta Incorporated
- Artur Mitterer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antidotes for factor Xa inhibitors and methods of using the same
- Patent number 10,675,335
- Issue date Jun 9, 2020
- Portola Pharmaceuticals, Inc.
- Genmin Lu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Mutated factor X polypeptides and uses thereof for the treatment of...
- Patent number 10,676,730
- Issue date Jun 9, 2020
- INSERM (Institut National de la Sante et de la Recherche Medicale)
- Olivier Christophe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for purifying FXa variant proteins
- Patent number 10,660,946
- Issue date May 26, 2020
- Pfizer Inc.
- Keith A. Johnson
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Mutated factor X polypeptides and uses thereof for the treatment of...
- Patent number 10,655,119
- Issue date May 19, 2020
- INSERM (Institut National de la Sante et de la Recherche Medicale)
- Olivier Christophe
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Non-cytotoxic protein conjugates
- Patent number 10,619,146
- Issue date Apr 14, 2020
- Ipsen Bioinnovation Limited
- Keith Foster
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Preparation of factor Xa derivatives
- Patent number 10,604,748
- Issue date Mar 31, 2020
- Portola Pharmaceuticals, Inc.
- Mark Karbarz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for counteracting Factor Xa inhibition
- Patent number 10,588,950
- Issue date Mar 17, 2020
- Pfizer Inc.
- Debra D. Pittman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Prohemostatic proteins for the treatment of bleeding
- Patent number 10,537,618
- Issue date Jan 21, 2020
- Academisch Ziekenhuis Leiden
- Daniël Verhoef
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Factor X mutants
- Patent number 10,364,424
- Issue date Jul 30, 2019
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Jean-Luc Plantier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Procoagulant compounds
- Patent number 10,287,564
- Issue date May 14, 2019
- Bioverativ Therapeutics Inc.
- Vu Phong Hong
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chimeric clotting factors
- Patent number 10,202,595
- Issue date Feb 12, 2019
- Bioverativ Therapeutics Inc.
- Joe Salas
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antidotes for factor Xa inhibitors and methods of using the same
- Patent number 10,190,111
- Issue date Jan 29, 2019
- Portola Pharmaceuticals, Inc.
- Uma Sinha
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
HIGHLY POTENT ISVD COMPOUNDS CAPABLE OF SUBSTITUTING FOR FVIII(A)
- Publication number 20240425837
- Publication date Dec 26, 2024
- Novo Nordisk A/S
- Andreas Vegge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROHEMOSTATIC PROTEINS FOR THE TREATMENT OF BLEEDING
- Publication number 20240390467
- Publication date Nov 28, 2024
- Academisch Ziekenhuis Leiden
- Daniël VERHOEF
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND MET...
- Publication number 20240189401
- Publication date Jun 13, 2024
- Alexion Pharmaceuticals, Inc.
- Uma Sinha
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
- Publication number 20240082367
- Publication date Mar 14, 2024
- Alexion Pharmaceuticals, Inc.
- Genmin Lu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PREPARATION OF FACTOR XA DERIVATIVES
- Publication number 20240076642
- Publication date Mar 7, 2024
- Alexion Pharmaceuticals, Inc.
- Mark Karbarz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HIGHLY POTENT ISVD COMPOUNDS CAPABLE OF SUBSTITUTING FOR FVIII(A)
- Publication number 20240067944
- Publication date Feb 29, 2024
- Novo Nordisk A/S
- Andreas Vegge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROCESS FOR MAKING RECOMBINANT ANTIDOTE TO FACTOR XA INHIBITOR
- Publication number 20230383276
- Publication date Nov 30, 2023
- Alexion Pharmaceuticals, Inc.
- Genmin Lu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND MET...
- Publication number 20230000957
- Publication date Jan 5, 2023
- Alexion Pharmaceuticals, Inc.
- Uma Sinha
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
- Publication number 20220354792
- Publication date Nov 10, 2022
- Alexion Pharmaceuticals, Inc.
- Phuong M. Nguyen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROHEMOSTATIC PROTEINS FOR THE TREATMENT OF BLEEDING
- Publication number 20220288172
- Publication date Sep 15, 2022
- Academisch Ziekenhuis Leiden
- Daniël VERHOEF
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR PREPARING FACTOR XA AND DERIVATIVES
- Publication number 20220251534
- Publication date Aug 11, 2022
- Alexion Pharmaceuticals, Inc.
- Genmin Lu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROCOAGULANT COMPOUNDS
- Publication number 20220243189
- Publication date Aug 4, 2022
- Bioverativ Therapeutics Inc.
- Vu Phong HONG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC CLOTTING FACTORS
- Publication number 20220135959
- Publication date May 5, 2022
- Bioverativ Therapeutics Inc.
- Joe SALAS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROCESS FOR MAKING RECOMBINANT ANTIDOTE TO FACTOR XA INHIBITOR
- Publication number 20220098565
- Publication date Mar 31, 2022
- Alexion Pharmaceuticals, Inc.
- Genmin Lu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
INHIBITION OF TISSUE FACTOR PATHWAY INHIBITOR WITH FACTOR XA DERIVA...
- Publication number 20210379163
- Publication date Dec 9, 2021
- Alexion Pharmaceuticals, Inc.
- Genmin Lu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIDOTES TO FACTOR XA INHIBITORS
- Publication number 20210371842
- Publication date Dec 2, 2021
- Alexion Pharmaceuticals, Inc.
- Pamela B. Conley
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CHIMERIC CLOTTING FACTORS
- Publication number 20210355473
- Publication date Nov 18, 2021
- Bioverativ Therapeutics Inc.
- Joe SALAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREPARATION OF FACTOR XA DERIVATIVES
- Publication number 20210348149
- Publication date Nov 11, 2021
- Alexion Pharmaceuticals, Inc.
- Mark Karbarz
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
- Publication number 20210340515
- Publication date Nov 4, 2021
- Alexion Pharmaceuticals, Inc.
- Uma Sinha
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROCESSABLE SINGLE CHAIN MOLECULES AND POLYPEPTIDES MADE USING SAME
- Publication number 20210292729
- Publication date Sep 23, 2021
- Bioverativ Therapeutics Inc.
- Joe Salas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
- Publication number 20210284986
- Publication date Sep 16, 2021
- Alexion Pharmaceuticals, Inc.
- Juan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS COMPRISING HETEROGENEOUS POPULATIONS OF RECOMBINANT HU...
- Publication number 20210106658
- Publication date Apr 15, 2021
- Pfizer Inc.
- KEITH A. JOHNSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND MET...
- Publication number 20210085762
- Publication date Mar 25, 2021
- Portola Pharmaceuticals, Inc.
- UMA SINHA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR COUNTERACTING FACTOR XA INHIBITION
- Publication number 20210000930
- Publication date Jan 7, 2021
- Pfizer Inc.
- Debra D. Pittman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MUTATED FACTOR X POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF...
- Publication number 20200299666
- Publication date Sep 24, 2020
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Olivier CHRISTOPHE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
- Publication number 20200299667
- Publication date Sep 24, 2020
- Portola Pharmaceuticals, Inc.
- Juan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
- Publication number 20200299668
- Publication date Sep 24, 2020
- Portola Pharmaceuticals, Inc.
- Juan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME
- Publication number 20200276280
- Publication date Sep 3, 2020
- Portola Pharmaceuticals, Inc.
- GENMIN LU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MUTATED FACTOR X POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF...
- Publication number 20200248162
- Publication date Aug 6, 2020
- Inserm (institut National de la Sante et de la Recherche Medicale)
- Olivier CHRISTOPHE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PREPARATION OF FACTOR XA DERIVATIVES
- Publication number 20200208131
- Publication date Jul 2, 2020
- Portola Pharmaceuticals, Inc.
- Mark Karbarz
- C07 - ORGANIC CHEMISTRY

Coagulation factor Xa (3.4.21.6)

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Highly potent ISVD compounds capable of substituting for FVIII(A)

Prohemostatic proteins for the treatment of bleeding

Lyophilized formulations for factor XA antidote

Preparation of factor Xa derivatives

Antidotes for factor Xa inhibitors and methods of using the same

Peptides that inhibit binding of EPCR to its ligand to treat inflam...

Prohemostatic proteins for the treatment of bleeding

Prohemostatic proteins for the treatment of bleeding

Procoagulant compounds

Chimeric clotting factors

Mutated factor X polypeptides and uses thereof for the treatment of...

Lyophilized formulations for factor Xa antidote

Chimeric clotting factors

Antidotes for factor Xa inhibitors and methods of using the same

Preparation of factor Xa derivatives

Processable single chain molecules and polypeptides made using same

Unit dose formulation of antidotes for factor Xa inhibitors and met...

Protein purification by anion exchange chromatography

Antidotes for factor Xa inhibitors and methods of using the same

Mutated factor X polypeptides and uses thereof for the treatment of...

Methods for purifying FXa variant proteins

Mutated factor X polypeptides and uses thereof for the treatment of...

Non-cytotoxic protein conjugates

Preparation of factor Xa derivatives

Compositions and methods for counteracting Factor Xa inhibition

Prohemostatic proteins for the treatment of bleeding

Factor X mutants

Procoagulant compounds

Chimeric clotting factors

Antidotes for factor Xa inhibitors and methods of using the same

Patents Applicationslast 30 patents

HIGHLY POTENT ISVD COMPOUNDS CAPABLE OF SUBSTITUTING FOR FVIII(A)

PROHEMOSTATIC PROTEINS FOR THE TREATMENT OF BLEEDING

UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND MET...

ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME

PREPARATION OF FACTOR XA DERIVATIVES

HIGHLY POTENT ISVD COMPOUNDS CAPABLE OF SUBSTITUTING FOR FVIII(A)

PROCESS FOR MAKING RECOMBINANT ANTIDOTE TO FACTOR XA INHIBITOR

UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND MET...

LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

PROHEMOSTATIC PROTEINS FOR THE TREATMENT OF BLEEDING

COMPOSITIONS AND METHODS FOR PREPARING FACTOR XA AND DERIVATIVES

PROCOAGULANT COMPOUNDS

CHIMERIC CLOTTING FACTORS

PROCESS FOR MAKING RECOMBINANT ANTIDOTE TO FACTOR XA INHIBITOR

INHIBITION OF TISSUE FACTOR PATHWAY INHIBITOR WITH FACTOR XA DERIVA...

ANTIDOTES TO FACTOR XA INHIBITORS

CHIMERIC CLOTTING FACTORS

PREPARATION OF FACTOR XA DERIVATIVES

ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME

PROCESSABLE SINGLE CHAIN MOLECULES AND POLYPEPTIDES MADE USING SAME

LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

COMPOSITIONS COMPRISING HETEROGENEOUS POPULATIONS OF RECOMBINANT HU...

UNIT DOSE FORMULATION OF ANTIDOTES FOR FACTOR XA INHIBITORS AND MET...

COMPOSITIONS AND METHODS FOR COUNTERACTING FACTOR XA INHIBITION

MUTATED FACTOR X POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF...

LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING THE SAME

MUTATED FACTOR X POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF...

PREPARATION OF FACTOR XA DERIVATIVES